Prevalence and Prognostic Role of L Wave and Selected Clinical and Echocardiographic Variables in Dogs with Atrial Fibrillation
Overview
Veterinary Medicine
Authors
Affiliations
Background: Information regarding the frequency of L waves and their prognostic relevance in dogs with secondary atrial fibrillation (AF) is limited.
Hypothesis/objectives: To determine whether L waves occur and ascertain their prognostic role, as well as the role of other clinical and echocardiographic variables in dogs with AF.
Animals: Fifty-five dogs with AF associated with myxomatous mitral valve disease or dilated cardiomyopathy.
Methods: Retrospective, multicenter observational study. In addition to L waves analysis, other clinical and echocardiographic variables, including type of antiarrhythmic treatment, were evaluated. A survival analysis was performed to test for predictors of cardiac death and all-cause mortality using Cox proportional hazards regression models.
Results: L waves were evident in 33/55 dogs (60%, 95% confidence interval [CI] = 47%-72%) but their presence did not influence outcome. Increased left ventricular end-systolic diameter normalized for body weight (LVSDn) was a significant predictor of both cardiac death (hazard ratio [HR] = 4.41, 95% CI = 1.18-16.54; P = .03) and all-cause mortality (HR = 9.39, 95% CI = 2.49-35.32; P < .001). Heart rate assessed during echocardiography (Echo-HR) represented an additional significant predictor of cardiac death (HR = 1.01, 95% CI = 1.00-1.01; P = .04) and all-cause mortality (HR = 1.01, 95% CI = 1.00-1.01; P = .04).
Conclusions And Clinical Importance: L waves occurred frequently in dogs with AF, but held no prognostic relevance. Conversely, LVSDn and Echo-HR represented independent predictors of negative outcome in these animals.
Kurogochi K, Nishiyama M, Masaki H, Asakawa M, Uechi M Vet Med Sci. 2025; 11(1):e70029.
PMID: 39812505 PMC: 11734185. DOI: 10.1002/vms3.70029.
Evaluation of Galectin-3 in Dogs with Atrial Fibrillation.
Arcuri G, Valente C, Romito G, Bonsembiante F, Mazzoldi C, Contiero B Animals (Basel). 2024; 14(17).
PMID: 39272333 PMC: 11394297. DOI: 10.3390/ani14172547.
Pedro B, Mavropoulou A, Oyama M, Linney C, Neves J, Dukes-McEwan J J Vet Intern Med. 2024; 38(4):2076-2088.
PMID: 38877661 PMC: 11256134. DOI: 10.1111/jvim.17120.
Risk Factors for Atrial Fibrillation in the Dog: A Systematic Review.
Arcuri G, Valente C, Perini C, Guglielmini C Vet Sci. 2024; 11(1).
PMID: 38275929 PMC: 10818451. DOI: 10.3390/vetsci11010047.
Risk factors for atrial fibrillation in dogs with dilated cardiomyopathy.
Guglielmini C, Valente C, Romito G, Mazzoldi C, Baron Toaldo M, Goncalves Sousa M Front Vet Sci. 2023; 10:1183689.
PMID: 37228845 PMC: 10203468. DOI: 10.3389/fvets.2023.1183689.